Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

EnsoData Applies AI to Address Health Concerns for 1,000,000 Patients Worldwide


News provided by

EnsoData

May 18, 2023, 09:00 ET

Share this article

Share toX

Share this article

Share toX


During the last five years, EnsoData pioneered the clinical use and adoption of AI and machine learning (ML) technology in healthcare

MADISON, Wis., May 18, 2023 /PRNewswire-PRWeb/ -- EnsoData, the AI healthcare technology company, announces it has assisted clinicians in diagnosing the one millionth patient supported by its AI/ML sleep scoring solution, EnsoSleep, marking a key milestone in its mission to make healthcare more accurate and affordable.

Supporting a network of more than 130 leading provider organizations, EnsoData is helping clinicians diagnose patients more quickly and accurately, allowing them to get patients the treatment they need for deadly sleep disorders, including obstructive sleep apnea (OSA). OSA affects an estimated 22 million Americans and one billion people worldwide. Critical yet often overlooked, the condition is highly comorbid with many of the chronic conditions leading American death rates and healthcare costs, including depression, heart disease, and obesity.

Now that we have helped clinicians read one million studies and reach one million patients, we’re only doubling down on our mission to positively impact patient care and make healthcare more accessible and affordable – to reach the next 10 million patients that need help.

Post this

The impact of this work is enormous: Earlier and more accessible diagnosis and treatment of OSA will dramatically transform the healthcare economy and save lives. Controlling healthcare costs and medical debt will transform the overall economy.

"Accelerating OSA diagnosis to this level was only possible through the team here harnessing the power of AI to automate a time-consuming and costly manual process," said Justin Mortara, President and CEO of EnsoData. "Our EnsoSleep AI solution creates efficiencies for health systems and clinicians that enable reinvestment in patient care and education, reduction in readmission rates for patients with comorbidities, and development of better screening programs to identify people with undiagnosed OSA."

EnsoData is considered a pioneer in the clinical use and adoption of AI and machine learning (ML) technology in healthcare, supporting leading providers and health systems like Rush University, Advanced Sleep Management, and CHI St. Joseph Health. The team published more than 30 peer-reviewed AI and ML research publications to uncover the extent of sleep's profound role and influence on health and disease, with another five publications coming at SLEEP 2023 in June.

"Long before AI solutions were mainstream, EnsoData persevered to earn trust and commercial adoption of our AI-based solution in the change-averse healthcare space," said Chris Fernandez, co-founder, Executive Chairman, and Chief Research Officer of EnsoData. "Now that we have helped clinicians read one million studies and reach one million patients, we're only doubling down on our mission to positively impact patient care and make healthcare more accessible and affordable – to reach the next 10 million patients that need help."

The pandemic has driven burnout among clinicians to crisis levels – causing hundreds of thousands of them to leave the workforce. Due to these staffing shortages, health care systems now face difficulties finding and retaining quality staff and serious financial challenges. EnsoData supports teams dealing with these challenges by automating the time consuming process of scoring Polysomnography (PSG) and Home Sleep Apnea Test (HSAT) sleep studies.

With over 450,000 PSG studies reviewed to date, at an average time savings of 28.1 minutes per PSG, down from 47.5 minutes before EnsoSleep to just 19.4 minutes after, that translates to 210,750 hours, or just over 24 years. For HSATs, time spent dropped from 25.5 minutes on average to just 8.3 minutes, saving 17.2 minutes per test.
"With EnsoSleep prescoring the studies, we're cutting into our backlog, and our patients have much shorter wait times for results. It's a win-win," said Dr. James Herdegen, Rush University Medical Center.

Extrapolate that time savings to the roughly 550,000 HSATs EnsoSleep supported, and the total is just under 18 years of saved time. In total, EnsoSleep saved approximately 42 years of time for clinicians and RPSGTs to repurpose into improving operational efficiency and enhancing patient care.

"EnsoSleep cuts the time in half for report preparation and it is vital to consistent scoring and reaching our volume goals," said Laura Linley, EVP of Clinical Operations, Co-Founder, Advanced Sleep Management.

As noted, EnsoSleep Study Management provides clinicians with a single, cloud-based platform for reviewing, editing, and reporting on sleep studies, leading to increased efficiency across the sleep lab workflow. The customizable, dynamic reports also simplify the report generation process for sleep labs, getting results back into patient hands more quickly.

"Reaching one million patients is just the beginning. Our dream is now a reality," said Sam Rusk, EnsoData co-founder, Chief AI Officer, and Member of the American Academy of Sleep Medicine AI Committee. "The one million patients analyzed by EnsoSleep have spent approximately 36 years of collective time in REM sleep, the stage where we dream. Here's to the next big goal for this dream team: 10 million patients."

About EnsoData
EnsoData strives to make healthcare more accurate, efficient, and affordable through waveform artificial intelligence (AI) technology. Using AI and machine learning, the software analyzes billions of data points collected from sensors placed throughout the human body. EnsoData's first solution, EnsoSleep, reduces the time clinicians spend analyzing, scoring and managing sleep studies. This results in a simplified and accelerated patient testing, diagnosis, and treatment workflow. The AI-powered technology has the capability of informing a future of health decisions beyond sleep medicine, from monitoring patient health in the ICU or through wearables, to detecting and capturing seizure data, to providing earlier detection of heart disease, diabetes, stroke, and Alzheimer's.

Learn more at ensodata.com.

###

Media Contact

Steven Miller, EnsoData, 3179899804, [email protected]

Tess Pawlisch, EnsoData, 3179899804, [email protected]

SOURCE EnsoData

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.